DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2203152/wall-street-analysts-see-stellantis-stla-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2203152 Dec 28, 2023 - Based on the average brokerage recommendation (ABR), Stellantis (STLA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.zacks.com/stock/news/2202219/morgan-stanley-ms-to-see-record-japan-income-as-trading-revives?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2202219 Dec 26, 2023 - Morgan Stanley (MS) expects record revenues from Japan on the back of the country's debt and rates market trading resurgence. 0

https://seekingalpha.com/news/4050285-cvrx-stock-gains-after-fda-label-update-barostim?source=feed_sector_healthcare Dec 26, 2023 - CVRx (CVRX) receives FDA approval for expanded labeling of its flagship product Barostim, that could lead to a higher market opportunity for the device. Read more here. 0

https://www.zacks.com/stock/news/2201594/wall-street-analysts-see-a-25-31-upside-in-dole-dole-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2201594 Dec 22, 2023 - The average of price targets set by Wall Street analysts indicates a potential upside of 25.3% in Dole (DOLE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 0

https://www.zacks.com/stock/news/2201596/wall-street-analysts-see-a-100-upside-in-quipt-home-medical-corp-qipt-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2201596 Dec 22, 2023 - The consensus price target hints at a 100% upside potential for Quipt Home Medical Corp. (QIPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. 0

https://www.fool.com/investing/2023/12/22/virgin-galactic-charts-path-to-survival/?source=iedfolrf0000001 Dec 22, 2023 - Could a rising stock price fix Virgin Galactic's biggest problem? 0

https://seekingalpha.com/news/4049484-agri-groups-urge-reopening-of-key-border-crossings-in-texas-railroad-operators-see-impact?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news Dec 21, 2023 - U.S. agricultural groups urge government to reopen two key rail crossings on the Texas-Mexico border, while railroad operators see impact. Read more here. 0

https://www.zacks.com/stock/news/2201050/wall-street-analysts-see-a-67-76-upside-in-exscientia-plc-sponsored-adr-exai-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2201050 Dec 21, 2023 - The consensus price target hints at a 67.8% upside potential for Exscientia PLC Sponsored ADR (EXAI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. 0

https://seekingalpha.com/article/4658818-vug-large-cap-growth-easing-new-year?source=feed_tag_etf_portfolio_strategy Dec 20, 2023 - While growth has been a big winner in 2022, I see reasons for caution as we enter the new year. See why I downgrade VUG fund from buy to hold. 0

https://www.zacks.com/stock/news/2200084/s-p-500-etf-sees-historic-21b-influx-amid-stock-surge?cid=CS-ZC-FT-etf_news_and_commentary-2200084 Dec 19, 2023 - SPDR S&P 500 ETF Trust (SPY), which tracks the S&P 500 Index, pulled in a massive $20.8 billion in a single day, Dec 15, according to Bloomberg Intelligence 0